Pain News and Research

Latest Pain News and Research

Exercise-based cardiac rehabilitation offers lasting heart health benefits

Exercise-based cardiac rehabilitation reduces hospital admissions by a third and heart attack risk by more than a quarter, as well as remaining beneficial in the long term, a new Cochrane review finds.

17 Sep 2026

New project aims to diagnose asthma in young children

Although asthma is the most common chronic condition in childhood, current tests can only diagnose it from the age of five.

17 Sep 2026

Study identifies key factors in breast cancer survivors' sexual recovery

Sexual wellbeing can often be overlooked during a woman's recovery from breast cancer with many continuing to experience significant sexual and intimacy challenges long after treatment ends.

17 Sep 2026

Post-concussion irritability linked to PTSD, chronic pain, and auditory difficulties

New research from the CU Anschutz Marcus Institute for Brain Health shows that irritability is strongly associated with post-traumatic stress disorder (PTSD) symptoms, chronic pain and difficulty understanding speech in noisy environments among military veterans with chronic mild traumatic brain injury (mTBI), or concussion.

17 Sep 2026

Innate immune system variations determine vaccine side effects

Redness and pain at the injection site, fever, fatigue or headaches: vaccines can cause side effects, but their frequency and severity vary considerably from person to person.

17 Sep 2026

Mindfulness and tai chi practices help cancer survivors manage symptoms

The cancer journey for many patients doesn’t end after treatment. Many live with long-term side effects that affect their ability to sleep and cause pain, impacting daily life.

16 Sep 2026

Targeted antibody therapy provides long-lasting relief from neuropathic pain

Pain is a natural protective mechanism that alerts the body to actual or potential injury. But when nerves themselves are damaged, they can generate abnormal pain signals even in the absence of a new injury.

16 Sep 2026

UCSF researchers urge more convincing placebos in psychedelic trials

UC San Francisco researchers are weighing in on one of the biggest challenges in psychedelic science, arguing that clinical trials need more convincing placebo treatments to better measure the drugs' true effects.

16 Sep 2026

Promising AI tool to speed up endometriosis diagnosis

Less than a second. That’s how long it takes for an emerging AI tool to detect signs of endometriosis through one simple scan. It’s a much faster process than the current seven-year wait for surgery and less invasive.

16 Sep 2026

Researchers build prognostic model to guide end-of-life care in metastatic breast cancer

Oncologists know that intensive treatment rarely helps patients in their final days but recognizing when someone is entering that stage is difficult, especially in metastatic breast cancer, where an increasing number of effective treatments has helped prolong life and given patients and oncologists more treatment options.

16 Sep 2026

Insilico Medicine launches AI initiative to develop longevity vaccines

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced Longevity Vaccines, a research initiative developing treatments that direct a patient's own immune cells to eliminate the earliest cellular drivers of age-related disease.

15 Sep 2026

FDA outlines key tips for safe tampon usage

If you use tampons during your period, it's important to know how to use them safely, and to understand how the U.S. Food and Drug Administration evaluates their safety and effectiveness.

15 Sep 2026

Wearable electroceutical platform enables remote wireless pain management

A "wearable electroceutical" has been developed that could reduce the need to visit a hospital or rely on painkillers every time pain occurs.

15 Sep 2026

AI identifies hidden biological patterns to accurately diagnose migraines

AI can trawl vast amounts of health data which is not specifically related to migraines, but which can be used to identify people predisposed to the condition.

11 Sep 2026

Liberian women face long waits for urgent fistula surgery

For more than three years, Lorpu has lived with the constant leakage of urine and faeces caused by obstetric fistula, a debilitating childbirth injury.

11 Sep 2026

Common medications trigger potentially harmful prescribing cascades in older adults

A new Ontario-wide study reveals that common medications, from statins to iron supplements, are quietly setting off prescribing cascades that leave older adults unknowingly taking drugs to treat side effects of other drugs.

10 Sep 2026

Review highlights solute carriers as targets for central nervous system disorders

Solute carriers (SLCs) are specialized transport proteins that control the movement of nutrients, ions and neurotransmitters across cell membranes and are essential for brain metabolism and neuronal communication.

10 Sep 2026

Generative AI-driven drug Rentosertib enters Phase III trial for idiopathic pulmonary fibrosis

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed the first patient with Rentosertib (known as ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial (NCT07687459, CTR20262475) at Peking Union Medical College Hospital, while Shanghai Pulmonary Hospital has also enrolled its first patient on the same day.

10 Sep 2026

Tizanidine looked promising early in a migraine trial, but the benefit did not last

A randomized, double-blind, placebo-controlled trial found that low-dose tizanidine did not provide sustained reductions in headache burden over 12 weeks in people with episodic migraine, despite a transient improvement with the 1 mg dose at week 4. Exploratory analyses suggested that smoking and sex may influence tizanidine exposure, while sex-specific efficacy signals remained hypothesis-generating and require confirmation.

10 Sep 2026

Minimum waits delay patient care across England, BMJ data reveals

Nearly half of health boards in England are deliberately delaying care for patients by imposing minimum waiting times in an attempt to manage demand and control costs, reveals exclusive data published by The BMJ today.

9 Sep 2026